MedPath

The effect of Transcutaneous Electrical Nerve (TENS) on the restless leg syndrome (RLS)

Phase 3
Conditions
Restless Legs Syndrome.
Restless legs syndrome
G25.81
Registration Number
IRCT20191217045764N1
Lead Sponsor
Esfarayen University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

People over 35 years old
Restless leg syndrome based on patient self-report
Restless leg syndrome based on a doctor's diagnosis And in the final step, score higher than 4 based on the standard questionnaire

Exclusion Criteria

There is a history of psychiatric illness except restless leg syndrome
Vascular diseases except restless leg syndrome according to physician
Neuromuscular Disorders (Technique Problem)
Experience the crisis over the past 3 months
Patient's unwillingness to cooperate in design
Severe stress to the individual or family over the past two weeks(death of a family member, ...)
Intensify of RLS
Use of antispasmodics over the past two weeks
Use of anticonvulsants in the past two weeks
Use of antidepressants over the past two weeks
Use of sedatives over the past two weeks
Using herbal remedies or any non-pharmacological treatments for treating restless legs syndrome over the past two weeks

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of restless leg syndrome. Timepoint: At the beginning of the study (before the intervention). Immediately after intervention on two occasions, twice a week (Twice in total), in each time an intervention. Method of measurement: Using the International Restless Legs Syndrome Study Group (IRLSS) questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath